共 185 条
[1]
Greene DA, Sima AAF, Stevens MJ, Feldman EL, Lattimer SA, Complications: neuropathy, pathogenetic considerations, Diabetes Care, 15, pp. 1902-1925, (1992)
[2]
Judzewitsch RG, Jaspan JB, Polonsky KS, Weinberg CR, Halter JB, Halar E, Pfeifer MA, Vukadinovic C, Bernstein L, Schneider M, Liang KY, Gabbay KH, Rubenstein AG, Porte D, Aldose reductase inhibition improves nerve conduction velocity in diabetic patients, N Engl J Med, 308, pp. 119-125, (1983)
[3]
Greene DA, Sima AAF, Aldose reductase inhibitor (ARI) treatment normalizes axo‐glial dysjunction and improves nerve fiber pathology in advanced diabetic neuropathy, Diabetes, 40, 1, (1991)
[4]
Sima AAF, Bril V, Nathanial V, McEwen TA, Brown M, Lattimer SA, Greene DA, Regeneration and repair of myelinated fibers in sural nerve biopsies from patients with diabetic neuropathy treated with an ARI, N Engl J Med, 319, pp. 548-555, (1988)
[5]
Report and recommendations of the San Antonio Conference on Diabetic Neuropathy, Diabetes, 37, pp. 1000-1004, (1988)
[6]
Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA
[7]
Dyck PJ, Karnes J, O'Brien PC, Diagnosis, staging, and classification of diabetic neuropathy and associations with other complications, Diabetic Neuropathy, pp. 36-44, (1987)
[8]
Greene DA, Sima AAF, Albers JW, Pfeifer MA, Diabetic neuropathy, Diabetes Mellitus, pp. 710-755, (1990)
[9]
Dyck PJ, Karnes JL, Daube J, O'Brien P, Service FJ, Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy, Brain, 108, pp. 861-880, (1985)
[10]
Britland ST, Young RJ, Sharma AK, Clarke BF, Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration, Diabetes, 39, pp. 898-908, (1990)